期刊文献+

骨保护素基因敲除对小鼠左心室收缩功能的影响

Effect of OPG knockout on left ventricular systolic function of mouse
下载PDF
导出
摘要 目的探讨左心室收缩功能与骨保护素配体(RANKL)和雌激素在骨保护素(OPG)基因敲除小鼠引起骨质疏松之间的关系。方法建立OPG基因敲除小鼠模型,并设对照组;ELISA法检测小鼠血清OPG和RANKL水平,放射免疫法检测血清雌激素水平;利用心脏超声对心功能进行评价。结果与对照组比较,OPG基因敲除组小鼠的心脏质量、心脏质量与体质量的比值、左室心肌细胞的横切面积均明显增大(P<0.01),左心室收缩末期内径和左心室收缩末期容积也明显增大(P<0.05)。OPG基因敲除组小鼠血清RANKL浓度明显高于对照组(P<0.001),两组血清雌激素水平则无显著差异(P>0.05)。结论OPG缺乏导致血清RANKL水平升高,左心室心肌细胞肥大,但不影响血清雌激素水平。 Objective To investigate the relationships between serum levels of receptor activator of nuclear factor-kappa B ligand ( RANKL), estrogen and heart function in osteoprotegerin (OPG) deficience-induced mouse osteoporosis. Methods OPG knockout mouse model and control group were established. Serum OPG and RANKL levels were measured by ELISA. Serum estrogen was detected by radioimmunology, and cardiac ultrasonography was performed to assess the heart function. Results The heart weight, the ratio of heart weight to body weight and transverse area of myocardial cells of left ventricle were significantly increased in OPG knockout mice compared to the control group ( P 〈 0.01 ). Left ventricular systolic diameter and left ventricular end-systolic volume in OPG knockout mice were significantly higher than those in the control group(P 〈 0.05). The serum RANKL level in OPG knockout mice was higher than that of the control group (P 〈 0. 001 ), while there was no significant change in the serum estrogen level(P 〉 0.05). Conclusion Deficience of OPG induces up-regulation of serum RANKL level and myocardial hypertrophy, but has no effect on serum estrogen level.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2008年第3期285-288,共4页 Journal of Shanghai Jiao tong University:Medical Science
基金 国家高技术研究发展计划(2001AA216081,2004AA216081) 国家自然基金杰出青年科学家基金(39925023) 国家教育部基金(00TPJS1111) 上海市科技发展基金(99JC14029,99XD14005) 上海市教育局E-研究院基金(E03003)~~
关键词 骨保护素 骨保护素配体 左心室 小鼠 osteoprotegerin receptor activator of nuclear factor-kappa B ligand left ventricular mouse
  • 相关文献

参考文献1

二级参考文献14

  • 1Tolar J,Teitelbaum S L,Orchard P J.Osteopetrosis.N Engl J Med,2004,351:2839~2849 被引量:1
  • 2Doherty T M,Fitzpatrick L A,Inoue D,et al.Molecular,endocrine,and genetic mechanisms of arterial calcification.Endocr Rev,2004,25:629~672 被引量:1
  • 3Schulz E,Arfai K,Liu X,et al.Aortic calcification and the risk of osteoporosis and fractures.J Clin Endocrinol Metab,2004,89:4246~4253 被引量:1
  • 4Bucay N,Sarosi I,Dunstan C R,et al.Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.Genes Dev,1998,12:1260~1268 被引量:1
  • 5Min H,Morony S,Sarosi I,et al.Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembing osteoclastogenesis.J Exp Med,2000,192:463~474 被引量:1
  • 6Hofbauer L C,Schoppet M.Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular disease.JAMA,2004,292:490~495 被引量:1
  • 7Nakamura,Udagawa N,Matsuura S,et al.Osteoprotegerin regulates bone formation through a coupling mechanism with bone resorption.Endocr,2003,144:5441 ~5449 被引量:1
  • 8Price P A,June H H,Buckley J R,et al.Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D.Arterioscler Thromb Vasc Biol,2001,21:1610~1616 被引量:1
  • 9Vattikuti R,Towler D A.Osteogenic regulation of vascular calcification:an early perspective.Am J Hysiol Endocrinol Metab,2004,286:686~696 被引量:1
  • 10Steitz S A,Speer M Y,Curinga G,et al.Smooth muscle cell phenotypic transition associated with calcification:upregulation of cbfa1 and downregulation of smooth muscle lineage markers.Circ Res,2001,89:1147~1154 被引量:1

共引文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部